Cardinal Health (CAH) FY2017 results: revenue $130.0 billion, up 6.9% on the year
Cardinal Health Inc. (CAH) reported revenue of $130.0 billion for fiscal 2017, the year ended 30 June 2017, up 6.9% on the year before. Net income was $1.3 billion, down 9.7%, and diluted earnings per share $4.03. The figures are the company's own, from the 10-K it filed with the SEC on 10 August 2017.
Revenue
$130.0 billion
+6.9% on the year
FY2010FY2017
Operating margin
1.6%
2.0% a year earlier
FY2010FY2017
Net income
$1.3 billion
-9.7% on the year
FY2010FY2017
Diluted EPS
$4.03
-6.7% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
129,976
121,546
102,531
+6.9%
Cost of revenue
123,432
115,003
96,819
+7.3%
Gross profit
6,544
6,543
5,712
+0.0%
Gross margin
5.0%
5.4%
5.6%
Selling, general and administrative
3,775
3,648
3,240
+3.5%
Operating income
2,120
2,459
2,161
-13.8%
Operating margin
1.6%
2.0%
2.1%
Interest expense
201
178
141
+12.9%
Pre-tax income
1,924
2,276
1,967
-15.5%
Income tax
630
845
755
-25.4%
Effective tax rate
32.7%
37.1%
38.4%
Net income
1,288
1,427
1,215
-9.7%
Net margin
1.0%
1.2%
1.2%
Diluted EPS
$4.03
$4.32
$3.62
-6.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
1,184
2,971
2,540
-60.1%
Capital expenditure
387
465
300
-16.8%
Free cash flow
797
2,506
2,240
-68.2%
Free cash flow margin
0.6%
2.1%
2.2%
Cash from investing
-405
-4,080
-849
Cash from financing
3,746
-1,139
60.0
Depreciation and amortisation
717
641
451
+11.9%
Share-based compensation
96.0
111
110
-13.5%
Buybacks
600
651
1,036
-7.8%
Dividends paid
577
512
460
+12.7%
Dividend per share
$1.80
$1.55
$1.37
+16.1%
Diluted shares, weighted
320m
330m
335m
-3.0%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
6,808
6,554
6,256
+3.9%
Non-controlling interest
20.0
17.0
0.0
+17.6%
Redeemable equity
118
117
0.0
+0.9%
Debt
10,395
5,539
5,492
+87.7%
Other liabilities
22,771
21,895
18,394
+4.0%
Total liabilities and equity
40,112
34,122
30,142
+17.6%
Fixed assets
1,879
1,796
1,506
+4.6%
Goodwill
7,221
7,167
5,070
+0.8%
Intangible assets
1,986
2,259
948
-12.1%
Investments
65.0
200
193
-67.5%
Cash and equivalents
6,879
2,356
4,616
+192.0%
Receivables
8,048
7,405
6,523
+8.7%
Inventory
11,301
10,615
9,211
+6.5%
Other assets
2,733
2,324
2,075
+17.6%
Total assets
40,112
34,122
30,142
+17.6%
10-K for the year ended 30 June 2017, filed 10 August 2017: the filing.